Heart muscle and plasma vitamin Q with heart transplantation

Canadian Journal of Cardiology

Volumn 13, Issue 2, 1997, Pages 147-152

  Karlsson, J ^a   Semb, B ^b  

^a OBLA AB   (Sweden)

^b NONE

Author keywords

Alpha tocopherol; Antioxidants; Free radicals; Heart muscle vitamin Q; Heart transplantation; Plasma vitamin E; Plasma vitamin Q; Ubiquinone

Indexed keywords

ALPHA TOCOPHEROL; UBIQUINONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HEART MUSCLE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEART VENTRICLE SEPTUM; HUMAN; HUMAN TISSUE; MALE; MUSCLE LEVEL; POSTOPERATIVE INFECTION; VITAMIN BLOOD LEVEL;

ADULT; BIOPSY; CHOLESTEROL; FEMALE; HEART SEPTUM; HEART TRANSPLANTATION; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIUM; ORGANIC CHEMICALS; TIME FACTORS; VITAMIN E; VITAMINS;

EID: 0030894030     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Pinsky DJ. The vascular biology of heart and lung preservation for transplantation. Thromb Haemost 1995;74:58-65.
2. Engler RE Free radical and granulocyte-mediated injury during myocardial ischemia and reperfusion. Am J Cardiol 1989;63:19E-23E.
3. Castagnetto M, Serino F, Lippa S, et al. Coenzyme Q, alpha-tocopherol, graft uptake and lipid peroxidation in human transplantation. In: Folkers K, Littarru GP, Yamagami T, eds. Biosynthesis and Regulation of Coenzyme Q. Amsterdam: Elsevier, 1991:465-9.
4. Laurent C, Johnson-Wells G, Hellström S, Engstrom-Laurent A, Wells A. Localization of hyaluronan in various muscular tissues: a morphological study in the rat. Cell Tissue Res 1991;263:201-5
5. Luft R. The development of mitochondrial medicine. Proc Natl Acad Sci USA 1994;91:8731-8.
6. Levine RL, Garland D, Oliver CN, et al. Determination of Carbinyl Content in Oxidatively Modified Protein. New York: Academic Press, 1990:464-78.
7. Ernster L, Forsmark P, Nordenbrand K. The mode of action of lipid-soluble antioxidants in biological membranes: relationship between the effects of ubiquinol and vitamin E as inhibitors of lipid peroxidation in submitochondrial particles. Biofactors 1992;3:241-8.
8. Stocker R, Bowrv VW, Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci USA 1991;88:1646-50.
9. Ernster L, Beyer RE. Antioxidant functions of coenzyme Q: some biochemical and pathophysiological implications. In: Folkers K, Littarru GP, Yamagami T, eds. Biomedical and Clinical Aspects of Coenzyme Q. Amsterdam: Elsevier, 1991:45-58.
10. Mortensen SA. Endomyocardial Biopsy. Copenhagen: Laegeforeningens Forlag, 1989:1-39.
11. Karlsson J, Diamant B, Theorell H, Johansen K, Folkers K. Plasma alpha-tocopherol and ubiquinone and their relations to muscle function in healthy human and in cardiac diseases. In: Packer L, Fuchs J, eds. Vitamin E: Biochemistry and Clinical Applications. New York: Marcel Dekker, Inc, 1993:473-93.
12. Karlsson J, Folkers K, Åstrom H, et al. Effect of Adriamycin® on heart and skeletal muscle Q in man. In: Folkers K, Yamamyra Y, eds. Biomedical and Clinical Aspects of Coenzyme Q. Amsterdam: Elsevier Science Publishers, 1986:241-5.
13. Elmberger PG, Kalén A, Appelkvist E-L, Dallner G. In vitro and in vivo synthesis of dolichol and other main mevalonate products in various organs of the rat. Eur J Biochem 1987;168:1-11.
14. Crane FL. Physiological coenzyme Q function and pharmacological reactions. In: Folkers K, Yamamyra Y, eds. Biomedical and Clinical Aspects of Coenzyme Q. Amsterdam: Elsevier, 1986:3-14.
15. 10, α-tocopherol and cholesterol in biological samples by coupled-column liquid chromatography with coulometric and ultraviolet detection. J Chromatogr 1988;425:87-97.
16. 10, alpha-tocopherol and free cholesterol in HDL and LDL fractions. Ann Med 1991;23:649-56.
17. Karlsson J, Diamant B, Folkers K, Edlund P-O, Lund B, Theorell H. Plasma ubiquinone and cholesterol contents with and without ubiquinone treatment. In: Lenaz G, Barnabei O, Rabbi A, Battino M, eds. Highlights in Ubiquinone Research. London: Taylor and Francis, 1990:296-302.
18. Horvitt MK, Harvey CC, Dahm JCH, Searcy MT. Relationship between tocopherol and serum lipid levels for determination of nutritional adequacy. Ann NY Acad Sci 1972;203:223-36.
19. Okamoto T, Matruya T, Fukunaga Y, Kishio T, Yamagami T. Human serum ubiquinol-10 levels and relationship to serum lipids. Int J Vit Nutr Res 1989;59:288-92.
20. 10 content in different parts of the normal human heart. Clin Physiol 1988;8:391-8.
21. Karlsson J, Diamant B, Edlund PO, Lund B, Folkers K, Theorell H. Plasma ubiquinone, alpha-tocopherol and cholesterol in man. Int J Vit Nutr Res 1992;62:160-4.
22. Jackson RL, Morrisett JD, Gotto AM. Lipoprotein structure and metabolism. Physiol Rev 1976;56:259-316.
23. Karlsson J, Diamant B, Theorell H, Folkers K. Ubiquinone and α-tocopherol in plasma; means of translocation or depot. Clin Invest 1993;71:S84-91.
24. Traber MG, Kayden HJ. Vitamin E is delivered to cells via the high affinity receptor for low density lipoprotein. Am J Nutr 1984;40:747-51.
25. Traber MG, Cohn W, Muller DPR. Absorption, transport and delivery to tissues. In: Packer L, Fuchs J, eds. Vitamin E in Health and Disease. New York: Marcel Dekker Inc, 1993:35-68.
26. Grant SC, Brooks NH. Accelerated graft atherosclerosis after heart transplantation. Br Heart J 1993;69:469-70.
27. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990;343:425-30.
28. Laaksonen R, Jokelainen K, Sahi T, Tikkanen MJ, Himberg JJ. Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue short-term simvastatin treatment in humans. Clin Pharmacol Ther 1995;57:62-6.
29. Folkers K, Langsjoen P, Willis R, et al. Lovastatin decreases coenzyme Q levels in humans. Proc Natl Acad Sci USA 1990;87:8931-4.
30. Mölgaard J, von Schenck H, Olsson AG. Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemia. Eur Heart J 1988,9:541-51.
31. Kiessling K-H, Pilström L, Karlsson J, Piehl K. Mitochondrial volume in skeletal muscle from young and old physically untrained and trained healthy men and from alcoholics. Clin Sci 1973;44:547-54.
32. Örlander J, Kiessling K-H, Karlsson J, Ekblom B. Low intensity training, inactivity and resumed training in sedentary men. Acta Physiol Scand 1977;101:351-62.
33. Bendich A. Vitamin E and human immune functions. In: Klurfeld DM, ed. Nutrition and Immunolgy. New York: Plenum Press, 1993:217-28.
34. 10 on the mediator cascade of sepsis. Circ Shock 1993;39:178-87.
35. Edlund C, Holmberg K, Dallner G, Norrby E, Kristensson K. Ubiquinone-10 protects neurons from virus induced degeneration. J Neurochem 1994;63:634-9.
36. Appelkvist E-L, Karlén A, Dallner G. Biosynthesis and regulation of coenzyme Q. In: Folkers K, Littarru GP, Yamagami T, eds. Biomedical and Clinical Aspects of Coenzyme Q. Amsterdam: Elsevier, 1991:141-50.
37. Crane FL, Sun IL, Sun EE. The essential functions of coenzyme Q. Clin Invest 1993,71:S55-9.
38. Mortensen SA, Bouchelouche P, Muratso K, Folkers K. Clinical decline and relapse of cardiac patients on coenzyme Q withdrawal. In: Folkers K, Yamamyra Y, eds. Biomedical Aspects of Coenzyme Q. Amsterdam: Elsevier, 1986:281-90.
39. 10. In: Lenaz G, Barnabei O, Rabbi A, Battino M, eds. Highlights in Ubiquinone Research. London: Taylor and Francis, 1990:226-31.
40. Karlsson J, Diamant B, Folkers K, et al. Ischemic heart disease, skeletal muscle fibers and exercise capacity. Eur Heart J 1992;13:758-62.
41. Karlsson J. The Antioxidant Strategy and Exercise. Champaign: Human Kinetics Publishers, Inc, 1996.
42. Karlsson J, Lin L, Gunnes S, Sylvén C, Åström H. Muscle ubiquinone in male effort angina patients. Mol Cell Biochem 1996;156:173-8.
43. Karlsson J, Gunnes S, Semb B. Muscle fibers, ubiquinone and exercise capacity in effort angina. Mol Cell Biochem 1996;156:179-84.